Patents by Inventor Lallan Giri

Lallan Giri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant immunogenic compositions and methods for protecting against lethal infections from
    Patent number: 7201912
    Abstract: Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis having a variant of recombinant Bacillus anthracis protective antigen (rPA) and a variant of recombinant Bacillus anthracis lethal factor (rLF). These proteins may be expressed separately or as a fusion protein. The recombinant proteins are produced in an avirulent strain of Bacillus anthracis that overproduces the desired antigens. The compositions and methods induce the animal host to produce antibodies against a virulent strain of Bacillus anthracis.
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: April 10, 2007
    Assignee: Emergent BioDefense Operation Lansing Inc.
    Inventors: Sukjoon Park, Lallan Giri
  • Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis
    Publication number: 20040028695
    Abstract: Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis having a variant of recombinant Bacillus anthracis protective antigen (rPA) and a variant of recombinant Bacillus anthracis lethal factor (rLF). These proteins may be expressed separately or as a fusion protein. The recombinant proteins are produced in an avirulent strain of Bacillus anthracis that overproduces the desired antigens. The compositions and methods induce the animal host to produce antibodies against a virulent strain of Bacillus anthracis.
    Type: Application
    Filed: March 28, 2003
    Publication date: February 12, 2004
    Inventors: Sukjoon Park, Lallan Giri